Also known as: Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica
Highest phase reached
Phase 3
First clinical trial
Last known activity
Jun 25, 2024
No events for the selected filters.
Phase 3 (1 own, 0 via acquisition)